If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Laura Carrassa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
trabectedin Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
DNA Damage Medicine & Life Sciences
Cell Line Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
M Phase Cell Cycle Checkpoints Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 702 Citations
  • 14 h-Index
  • 22 Article
  • 2 Review article

DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas

Restelli, V., Lupi, M., Chilà, R., Vagni, M., Tarantelli, C., Spriano, F., Gaudio, E., Bertoni, F., Damia, G. & Carrassa, L., Jul 2019, In : Molecular Cancer Therapeutics. 18, 7, p. 1255-1264 10 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
DNA Damage
Mantle-Cell Lymphoma
Lymphoma
Lymphoma, Large B-Cell, Diffuse

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin

Bello, E., Brich, S., Craparotta, I., Mannarino, L., Ballabio, S., Gatta, R., Marchini, S., Carrassa, L., Matteo, C., Sanfilippo, R., Gronchi, A., Casali, P. G., Pilotti, S., D’Incalci, M. & Frapolli, R., Sep 10 2019, In : British Journal of Cancer. 121, 6, p. 464-473 10 p.

Research output: Contribution to journalArticle

trabectedin
Myxoid Liposarcoma
Heterografts
Nude Mice
Therapeutics

A High-throughput Screening of a Chemical Compound Library in Ovarian Cancer Stem Cells

Ricci, F., Carrassa, L., Christodoulou, M. S., Passarella, D., Michel, B., Benhida, R., Martinet, N., Hunyadi, A., Ioannou, E., Roussis, V., Musso, L., Dallavalle, S., Silvestri, R., Westwood, N., Mori, M., Ingallina, C., Botta, B., Kavetsou, E., Detsi, A., Majer, Z. & 7 others, Hudecz, F., Bosze, S., Kaminska, B., Hansen, T. V., Bertrand, P., Athanassopoulos, C. M. & Damia, G., 2018, In : Combinatorial Chemistry and High Throughput Screening. 21, 1, p. 50-56 7 p.

Research output: Contribution to journalArticle

Small Molecule Libraries
Chemical compounds
Neoplastic Stem Cells
Stem cells
Ovarian Neoplasms

Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines

Restelli, V., Lupi, M., Vagni, M., Chilà, R., Bertoni, F., Damia, G. & Carrassa, L., Apr 2018, In : Targeted Oncology. 13, 2, p. 235-245 11 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cell Line
Checkpoint Kinase 1
PCI 32765
Therapeutics

PQR309 is a novel dual PI3K/mTOR inhibitor with preclinical antitumor activity in lymphomas as a single agent and in combination therapy

Tarantelli, C., Gaudio, E., Arribas, A. J., Kwee, I., Hillmann, P., Rinaldi, A., Cascione, L., Spriano, F., Bernasconi, E., Guidetti, F., Carrassa, L., Pittau, R. B., Beaufils, F., Ritschard, R., Rageot, D., Sele, A., Dossena, B., Rossi, F. M., Zucchetto, A., Taborelli, M. & 11 others, Gattei, V., Rossi, D., Stathis, A., Stussi, G., Broggini, M., Wymann, M. P., Wicki, A., Zucca, E., Cmiljanovic, V., Fabbro, D. & Bertoni, F., Jan 1 2018, In : Clinical Cancer Research. 24, 1, p. 120-129 10 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Lymphoma
Proteomics
Gene Expression
Gene Expression Profiling